[1] |
LIU Xuan, FENG Cuijuan, WANG Yiqiang, LI Fang.
Research progress of miRNA in ulcerative colitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 917-929.
|
[2] |
LIU Yuru, WU Wenwen, WANG Gang.
Navafenterol, a new drug for the treatment of chronic obstructive airway disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 401-405.
|
[3] |
LI Guanghui, HUANG Jing, ZHU Min, ZHAO Rui, WAN Yakun, CHEN Zhihong.
Progress and prospect of inhaled biological agents in asthma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 406-414.
|
[4] |
SUN Ao, WANG Jingluan, LIU Wenjuan, REN Dunqiang, LIU Xiaojing.
Immunologic characteristics and management and prospects of targeted biological therapy in adults with severe asthma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 415-422.
|
[5] |
MOU Duo, LIU Kexin, CHANG Chun.
Value of biotargeted drugs in airway mucus therapy of asthma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 423-426.
|
[6] |
WANG Linlin, MA Yuan, CHEN Zhihong, JI Haiying .
Progress in the application of AIT in allergic airway diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 427-431.
|
[7] |
ZHU Li, WEI Bing, LIAO Shi'e, ZHANG Chao, ZHENG Xiaoyu, LIU Yajun.
Effects of single nucleotide polymorphism of drug metabolizing enzyme cytochrome P450 on the efficacy of inhaled cortisol hormone in asthmatic children
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 536-543.
|
[8] |
ZHANG Zhiying, JIN Xiuhong, ZHANG Xiaoning, ZHANG Xiangfeng, LUO Qinglin, ZHANG Songlin.
Clinical study of TBX21 and ADCY9 polymorphisms in the develop- ment of childhood asthma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 407-412.
|
[9] |
MA A'xue, LU Xiaohong, DONG Bo, WANG Dong.
Research progress of exosomal miRNA in skin wound healing and regeneration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 919-924.
|
[10] |
WU Shuai, YANG Jun, ZHENG Yun.
Dual role of miRNA in breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 814-821.
|
[11] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[12] |
ZHOU Guangchen, LIU Yixi, ZHENG Yun.
Colorectal cancer and microRNA: research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 575-587.
|
[13] |
ZHAO Ziwen, FAN Fangtian, JIANG Zhijun.
Induced bronchial associated lymphoid tissue (iBALT) formation and research of related lung diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 353-360.
|
[14] |
ZHANG Jianmin, LENG Yufang, LIU Xin, REN Yixing, SHI Yajing, CHEN Feng.
Research progress on the mechanism of miRNA in intestinal ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 332-340.
|
[15] |
LI Jing, Ma Lijuan, YUAN Yuan, WANG Jie, YU Changzhi, ZHAO Jun.
Relationship between gene polymorphism of inhaled glucocorticosteroids budesonide and efficacy in asthma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1250-1258.
|